1 August 2024
This update brings significant changes for patients and healthcare providers:
It’s important to note that while the supply situation has improved, patients should consult with their healthcare providers regarding any changes to their treatment regimen.
17 May 2024
Pharmacists are now able to substitute Orencia prefilled syringe with the ClickJect (autoinjector) depending on stock levels.
Patients may need to switch between the Orenicia prefilled syringe and the ClickJect (autoinjector) over the coming months due to the ongoing shortage of Abatacept. It is important to know:
If your pharmacist offers you a substitute please make sure:
If you have any concerns or questions speak with your specialist and ask them to show you how to use both products so you are aware in the event you are offered a susbstitute.
As always, talk to your pharmacist or your specialist if you have any questions.
16 May 2024
The Government has released further information regarding current Abatacept shortage (refer to LINK ).
It is estimated two thirds of patients currently prescribed Abatacept will need to be moved to other medications where possible.
Patients unable to be moved to other medications will require their Rheumatologist to complete the necessary eligibility form.
All consumers currently prescribed Abatacept are strongly encouraged to take the following actions as a matter of priority:
Read more
TGA: Medicine Shortages Information Initiative | Therapeutic Goods Administration (TGA)
Rheumatology Republic: Abatacept shortage strikes again – Rheumatology Republic
Help Line
If this article has raised concerns for you, please call the nurse on our FREE Help Line Monday to Thursday from 9am to 5pm (excluding Public Holidays) on 1800 263 265 or email helpline@msk.org.au